Human capital and agency effects on CEO compensation of IPO biopharmaceutical firms and the market’s response

被引：2

作者：

Williams D.R. ^{[1
]}

Coffey B.S. ^{[2
]}

Young C.C. ^{[3
]}

机构：

[1] Health Care Management Program, Department of Nutrition and Health Care Management, Beaver College of Health Sciences, ASU, Box 32168, Boone, 28608, NC

[2] Department of Management, Walker College of Business, Appalachian State University, Boone, 28608, NC

[3] Division of Business, Mississippi State University, Meridian, 39301, MS

来源：

Journal of Management and Governance | 2018年 / 22卷 / 2期

关键词：

Agency issues; CEO compensation; Human capital effects; Initial public offering;

D O I：

10.1007/s10997-017-9389-1

中图分类号：

学科分类号：

摘要：

This paper examines the determinants of base pay and total incentive compensation packages of CEOs of biopharmaceutical firms that have recently gone public, and whether human capital and agency factors affect the market’s response to the initial public offering. We find that in terms of net proceeds, the IPO market appears to reward the firms that have founder-CEOs and CEOs with higher incentive compensation. CEOs with prior venture capital experience are associated with receiving higher incentive compensation, while CEOs with a greater ownership interest in the firm receive lower incentive compensation but higher salaries. CEOs of firms with a greater percentage of insiders are associated with lower salaries. The results should add to our understanding related to human capital and agency theories, as well as help firms and investors better understand and structure CEO compensation. © 2017, Springer Science+Business Media, LLC.

引用

页码：315 / 337

页数：22

共 50 条

[1] Capital market liability of foreignness of IPO firms
Tupper, Christina H.
Guldiken, Orhun
Benischke, Mirko
[J]. JOURNAL OF WORLD BUSINESS, 2018, 53 (04) : 555 - 567
[2] Specificity of CEO human capital and compensation
Harris, D
Helfat, C
[J]. STRATEGIC MANAGEMENT JOURNAL, 1997, 18 (11) : 895 - 920
[3] Firm-Specific Human Capital and Governance in IPO Firms: Addressing Agency and Resource Dependence Concerns
Arthurs, Jonathan D.
Busenitz, Lowell W.
Hoskisson, Robert E.
Johnson, Richard A.
[J]. ENTREPRENEURSHIP THEORY AND PRACTICE, 2009, 33 (04) : 845 - 865
[4] Human and financial capital as determinants of biopharmaceutical IPO de-listings
Williams, David R.
[J]. JOURNAL OF BUSINESS RESEARCH, 2013, 66 (12) : 2612 - 2618
[5] The effects of corporate acquisitions on CEO compensation and CEO turnover of family firms
De Cesari, Amedeo
Gonenc, Halit
Ozkan, Neslihan
[J]. JOURNAL OF CORPORATE FINANCE, 2016, 38 : 294 - 317
[6] Board's human capital resource and internationalization of emerging market firms: Toward an integrated agency-resource dependence perspective
Purkayastha, Anish
Karna, Amit
Sharma, Sunil
Bhadra, Dhiman
[J]. JOURNAL OF BUSINESS RESEARCH, 2021, 135 : 391 - 407
[7] Firms' main market, human capital, and wages
Alcala, Francisco
Hernandez, Pedro J.
[J]. SERIES-JOURNAL OF THE SPANISH ECONOMIC ASSOCIATION, 2010, 1 (04): : 433 - 458
[8] Firms’ main market, human capital, and wages
Francisco Alcalá
Pedro J. Hernández
[J]. SERIEs, 2010, 1 : 433 - 458
[9] Human Capital and CEO Compensation during Institutional Transitions
Peng, Mike W.
Sun, Sunny Li
Markoczy, Livia
[J]. JOURNAL OF MANAGEMENT STUDIES, 2015, 52 (01) : 117 - 147
[10] Equity market timing and capital structure: evidence on post-IPO firms in Indonesia
Ratih, Dewi
[J]. INTERNATIONAL JOURNAL OF EMERGING MARKETS, 2021, 16 (02) : 391 - 407

← 1 2 3 4 5 →